- Home
- VMC vs ZTS Comparison
VMC vs ZTS Comparison
Compare VMC & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VMC | ZTS |
|---|---|---|
| Founded | 1909 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.2B | 29.0B |
| IPO Year | 2007 | 2012 |
Fundamental Metrics
Financial Performance| Metric | VMC | ZTS |
|---|---|---|
| Price | $264.37 | $79.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 24 | 18 |
| Target Price | ★ $308.30 | $93.47 |
| AVG Volume (30 Days) | 1.2M | ★ 2.9M |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | 0.79% | ★ 2.65% |
| EPS Growth | ★ 18.39 | 10.05 |
| EPS | 1.26 | ★ 3.08 |
| Revenue | $7,781,900,000.00 | ★ $9,467,000,000.00 |
| Revenue This Year | $2.55 | N/A |
| Revenue Next Year | $5.05 | $2.43 |
| P/E Ratio | $208.15 | ★ $25.93 |
| Revenue Growth | ★ 6.38 | 2.28 |
| 52 Week Low | $237.03 | $68.92 |
| 52 Week High | $331.09 | $147.93 |
Technical Indicators
Market Signals| Indicator | VMC | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 65.83 | 66.76 |
| Support Level | $252.39 | $72.36 |
| Resistance Level | $281.19 | $80.17 |
| Average True Range (ATR) | 5.16 | 1.71 |
| MACD | 3.09 | 0.94 |
| Stochastic Oscillator | 95.25 | 88.27 |
Price Performance
Historical ComparisonAbout VMC Vulcan Materials Company (Holding Company)
Vulcan Materials is the United States' largest producer of construction aggregates (crushed stone, sand, and gravel). Its largest markets include Texas, California, Virginia, Tennessee, Georgia, Florida, North Carolina, and Alabama. In 2024, Vulcan sold 219.9 million tons of aggregates, 13.6 million tons of asphalt mix, and 3.6 million cubic yards of ready-mix. As of Dec. 31, 2024, the company had 16.5 billion tons of aggregate reserves.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.